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Neural crestThe severity of numerous developmental abnormalities can vary widely despite shared genetic causes. Mice
deﬁcient in Twisted gastrulation (Twsg1−/−) display such phenotypic variation, developing a wide range of
craniofacial malformations on an isogenic C57BL/6 strain background. To examine the molecular basis for this
reduced penetrance and variable expressivity, we used exon microarrays to analyze gene expression in
mandibular arches from several distinct, morphologically deﬁned classes of Twsg1−/− and wild type (WT)
embryos. Hierarchical clustering analysis of transcript levels identiﬁed numerous differentially expressed
genes, clearly distinguishing severely affected and unaffected Twsg1−/− mutants from WT embryos. Several
genes that play well-known roles in craniofacial development were upregulated in unaffected Twsg1−/−
mutant embryos, suggesting that they may compensate for the loss of TWSG1. Imprinted genes were
overrepresented among genes that were differentially expressed particularly between affected and
unaffected mutants. The most severely affected embryos demonstrated increased p53 signaling and increased
expression of its target, Trp53inp1. The frequency of craniofacial defects signiﬁcantly decreased with a
reduction of p53 gene dosage from 44% in Twsg1−/−p53+/+ pups (N=675) to 30% in Twsg1−/−p53+/−
(N=47, p=0.04) and 15% in Twsg1−/−p53−/− littermates (N=39, p=0.001). In summary, these results
demonstrate that phenotypic variability in Twsg1−/−mice is associated with differential expression of certain
developmentally regulated genes, and that craniofacial defects can be partially rescued by reduced p53 levels.
We postulate that variable responses to stress may contribute to variable craniofacial phenotypes by
triggering differential expression of genes and variable cellular apoptosis.13-124 PWB, MMC 8404, 516
12 626 5262.
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
Phenotypic variation is a well-known phenomenon in a number of
developmental abnormalities. For example, patients with Treacher-
Collins syndrome or holoprosencephaly (HPE) have an extremely
wide range of clinical manifestations (Hansen et al., 1996; Muenke
and Cohen, 2000; Roessler et al., 1996). In HPE, the most severe
defects, such as cyclopia, are usually incompatible with life, whileothers including hypotelorism or microphthalmia represent milder
forms (Ming et al., 2002). However, the molecular basis for such
reduced penetrance and variable severity, even in the context of the
same mutations on the same genetic background, has remained
unclear.
Differences in genetic background and environmental inﬂuences
are thought to be two major drivers of transcriptional variation,
leading to phenotypic variation or reduced penetrance in both
humans and mice (Butchbach et al., 2009; Champy et al., 2008). The
contribution of epigenetic phenomena, including DNA methylation
and histone modiﬁcation, has also been increasingly recognized to be
an important mechanism underlying variability in genetic expressi-
vity, particularly in the case of imprinted genes (Dindot et al., 2009;
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tions of the Silver-Russell syndrome correlate with the degree of
methylation at the H19-(Insulin-like Growth Factor) IGF2 locus
(Bruce et al., 2009). This underscores the importance of a better
understanding of the basis of phenotypic variation of craniofacial
malformations and identiﬁcation of mammalian models that would
facilitate such insights. An advantage in using inbredmousemodels to
study such phenotypic variation is that both strain differences and
environmental differences can be controlled.
We previously reported that disruption of Twisted gastrulation
(Twsg1), a modulator of BMP signaling, in mice leads to a spectrum of
craniofacial defects on an isogenic, inbred C57BL/6 background
(MacKenzie et al., 2009; Petryk et al., 2004). Within a single litter,
some mice are born with normal craniofacial structures; some have
mild defects, such as micrognathia and microphthalmia; and still
others have profound craniofacial abnormalities including anterior
truncation, cyclopia, agnathia, and HPE. While some of this variation
could be attributed to a variable extent of apoptosis and thus variable
loss of ﬁrst branchial arch 1 (BA1) derivatives (MacKenzie et al.,
2009), the underlying molecular mechanisms are not entirely
understood. Manifestation of craniofacial defects is highly strain
background-dependent and appears in about 40% of Twsg1−/− mice
on the C57BL/6 background. In early generations after derivation of
the mutant allele on the C57BL/6 background, some as yet
undiscoveredmodiﬁer gene/s could partially account for the observed
variation. However, this variation has persisted despite serial back-
crossing of themutant alleles onto the isogenic strain background. The
ongoing occurrence of extreme differences in phenotypes, even
within the same litter, raises the question of how phenotypic variation
might occur despite virtually no differences in inherited genes. The
Twsg1 mutant mouse model provides an excellent, well-controlled
experimental system in which to study the molecular mechanisms
underlying the resulting phenotypic variation and reduced
penetrance.
In this study, we have analyzed transcriptional changes that are
associated with development of distinct classes of craniofacial
phenotypes in Twsg1 mutant mice. We anticipated that these
differentially expressed transcripts would include previously un-
known effectors of the mutant phenotype as well as genes that may
compensate for the loss of TWSG1 and account for incomplete
penetrance of Twsg1 mutation. In particular, we were interested in
identifying transcriptional differences between unaffected and affect-
ed mutants that would shed light on potential mechanisms that allow
an organism to cope with a predisposition to disease.
Material and methods
Mice and tissue collection
Generation and genotyping of mice deﬁcient for TWSG1 (Petryk
et al., 2004), p53 (Donehower et al., 1992) as well as transgenic
Sox10Cre mice that express Cre recombinase in neural crest cells
(NCC) (Matsuoka et al., 2005) have been previously reported. To
generate mice with NCC-speciﬁc deletion of Twsg1 (Twsg1ﬂox/ﬂox;
Sox10Cre), mice carrying a conditional allele of Twsg1 (Twsg1ﬂox/ﬂox),
with exon 4 (coding exon 3) ﬂanked by loxP sites, were mated to
Sox10-Cre mice to generate Twsg1ﬂox/WT; Sox10Cre, which were then
mated to Twsg1ﬂox/ﬂox mice. All strains were on C57BL/6 background.
Presence of a spermatic plug was counted as day 0.5 post conception
(E0.5). Twsg1−/− embryos were classiﬁed as previously published as
class A (phenotypically the same as wild type), class B (moderately
affected), and class C (severely affected) (MacKenzie et al., 2009). For
microarray analysis, mandibular prominences of BA1s from mutants
of various phenotypic classes and WT embryos at E10.5 were
dissected by cutting the BA1 at the junction between the maxillary
and mandibular components using alkali etched tungsten needles.BA1s were ﬂash-frozen in liquid nitrogen and stored at−80 °C. Both
maxillary and mandibular prominences were dissected at E11.5 to
conﬁrm deletion of exon 4 of Twsg1 in NCC-derived tissues. This
embryonic stage was chosen to allow the analysis of individual
samples in case of variable efﬁciency of Cre-mediated recombination.
Use and care of the mice in this study was approved by the University
of Minnesota Institutional Animal Care and Use Committee.
RNA isolation
Frozen tissue samples were thawed in Trizol reagent (Invitrogen,
Carlsbad, CA) and pooled according to the phenotypic class. RNA was
puriﬁed using RNeasy micro kit spin columns (Qiagen, Valencia, CA).
Five biological replicates of each mutant class and of WT (each
representing a pool of 4–7 arches) were analyzed to achieve adequate
statistical power for this microarray analysis (Pavlidis et al., 2003).
Pooling was necessary to allow collection of sufﬁcient RNA for
microarray analysis (Bobola et al., 2003; Feng et al., 2009).
Microarray analysis
Microarray analysis was performed at the Kimmel Cancer Center
Cancer Genomics Core Facility, Thomas Jefferson University (Phila-
delphia, PA). Total RNA (50 ng) was used to prepare ampliﬁed cDNA
using the WT-Ovation Pico RNA ampliﬁcation system (NuGen
Technologies, Inc., San Carlos, CA). Sense transcript cDNA (ST-cDNA)
was generated from 3 μg of ampliﬁed cDNA. Finally, 5.0 μg ST-cDNAs
were labeled using FL-Ovation cDNA biotin module v2 (NuGen
Technologies, Inc.) (Linton et al., 2009). Affymetrix GeneChip mouse
exon 1.0 ST arrays (Affymetrix, Santa Clara, CA) were used following
manufacturer's recommendations. Samples were hybridized over-
night, scanned and processed using Command Console Software.
Background correction and normalization were done using Robust
Multichip Average (RMA) with Genespring v10.0 software (Agilent,
Palo Alto, CA, USA).
Bioinformatics analysis
mRNA expression proﬁle data were condensed using RMA to
generate raw expression values log base 2. Two group T-tests were
used to assess signiﬁcance in pairwise comparisons between groups
with correction for a false discovery rate (FDR) of 10% or less
(Benjamini and Hochberg, 1995). For inclusion in WT vs. C and A vs. C
analyses, genes were also required to have an absolute value of fold
change ≥1.5. Heatmaps were generated using Cluster3.0 and
JavaTreeview. Expression proﬁles were clustered in both supervised
and unsupervised methods to identify molecular patterns present in
the data. Ingenuity Pathways Analysis (IPA; Ingenuity® Systems,
www.ingenuity.com) was used to identify biological functions
regulated by differentially expressed genes.
Quantitative PCR
Reverse transcription was carried out with the Thermoscript RT kit
(Invitrogen) priming with random hexamers, followed by quantitative
PCR (Q-PCR,MX3000p, Agilent, LaJolla, CA) using expression assays from
Applied Biosystems (Foster City, CA) for Bambi (Mm03024088_g1),
Bmp4 (Mm00432087_m1), Bmpr1b (Mm03023971_m1), Cyp26a1
(Mm00514486_m1) , Dkk1 (Mm00438422_m1) , Gpr50
(Mm00439147_m1) , P e g3 (Mm00493299_s1 ) , P l a g l 1
(Mm00494250_m1), Satb2 (Mm00507337_m) or using published
primer sequences with SYBR green RT2 master mix (SABiosciences,
Valencia, CA) forDlk1, Igf2 (Varrault et al., 2006), andMsx2 (Berdal et al.,
2009). To detect Twsg1, the following primers were used (forward:
5′-CTGAACTGGAACATCGTCTC-3′, reverse: 5′-GCAGTCATCAAAG-
TAAACCAC-3′). Trp53inp1was detected with primers from the MGH
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forward: 5 ′-AAGTGGTCCCAGAATGGAAGC-3 ′ , reverse: 5 ′-
GGCGAAAACTCTTGGGTTGT-3′). All samples were normalized to
GAPDH (forward: 5′-TGCACCACCAACTGCTTAG-3′, reverse: 5′-
GATGCAGGGATGATGTTC-R for SYBR green assays; Applied Biosys-
tems 4352339E for TaqMan assays). Assays were run in triplicate
using N≥3 pooled cDNA samples per probe.
In situ hybridization
In situ hybridization was performed by standard methods (Sasaki
and Hogan, 1993). cDNA probe fragments for Plagl1 (Tsuda et al.,
2004), Peg3 (Kuroiwa et al., 1996) and Satb2 (FitzPatrick et al., 2003)
were ampliﬁed from a cDNA library obtained from E10.5 embryos and
cloned into the pCRII-TOPO vector (Invitrogen). A probe for Dkk1was
a gift from Dr. William Shawlot (Finley et al., 2003). Msx2 probe was
previously published (MacKenzie et al., 1992). Clones were tran-
scribed to generate digoxigenin labeled probes using a DIG RNA
labeling kit (Roche, Indianapolis, IN). At least 2–3 embryos were
evaluated in each phenotypic class per probe.
Western Blotting
E10.5 embryos were isolated from pregnant females set up in
timed matings, in ice-cold Tris buffered saline with EDTA (50 mM
TrisHCl pH7.4, 150 mM NaCl, 1 mM EDTA). Embryos were homog-
enized in lysis buffer (Tris buffered saline with 1% TritonX-100),
centrifuged for 10 min at 10,000 g at 4 °C, and supernatants were
electrophoresed in a 10% polyacrylamide gel using the NextGel
system (Amresco, Solon, OH). Proteins were transferred to Immo-
bilonFL PVDF membranes (Millipore, Billerica, MA) and probed with
an anti p53 mouse monoclonal antibody at 1:1000 (clone 1C12,
#2524, Cell Signaling Beverly, MA). The immunoblot was imaged
with HRP conjugated anti mouse IgG secondary at 1:2500 (Promega,
Madison, WI) and peroxide/luminol chemiluminescence with the
SuperSignal West Pico kit (Pierce/Thermoﬁsher, Rockford, IL). For
loading control blots were re-probed with mouse monoclonal anti-
GAPDH at 1:5000 (AM4300, Ambion, Foster City, CA) and imaged
with goat anti mouse secondary conjugated to IR800 ﬂuorophore atFig. 1. Association between phenotypic classes and expression differences. (A) Morphologic
outline themandibular components of BA1. (B): Gene expression levels are expressed on a log
represents a biological replicate from given phenotypic classes (WT, A, B, or C). Genes that ar
greater and a false discovery rate of 10% or less, are highlighted (red). Compared withWT gen
(C) Unsupervised hierarchical clustering of array data. Class C samples are clearly separated
alternatively with either A or C. The log2 scale of the expression values is shown in the key a1:5000 on the LICOR Odyssey system (Lincoln, NE). Three samples
per phenotypic class were analyzed.
Statistical analyses
Student's t-tests and Pearson's correlations of Q-PCR data were
performed in Prism 4 (GraphPad Software, LaJolla, CA). Signiﬁcance
was set at pb0.05. The incidence of Mendelian ratios and normal vs.
abnormal phenotype incidence for Twsg1;p53 mice were compared
using Chi-squared analyses and Chi-squared goodness of ﬁt tests.
Results
Transcriptional changes correlate with classes of phenotypic severity
We previously classiﬁed Twsg1−/− embryos based on the severity
of the phenotype into three classes at E9.5 (MacKenzie et al., 2009).
Similarly, at E10.5, class A (unaffected) mutant embryos are
morphologically indistinguishable from normal, wild type (WT)
embryos, while class B embryos exhibit partial midline fusion of the
mandibular components of BA1, and class C embryos have severe
midline fusion (Fig. 1A). To determine if these phenotypic classes are
associated with differences between their transcriptomes, we used
mouse exon microarrays to analyze total RNAs isolated from BA1
samples at E10.5. Differences in gene expression between the classes
increased with increasing phenotypic severity, and thus were greatest
in the most severely affected (class C) embryos (Fig. 1B).
Hierarchical clustering analysis was performed on the transcript
expression proﬁles of a set of 127 genes exhibiting the greatest
differences in expression between any two pools (Fig. 1C). This
analysis clearly distinguished class C phenotypic samples from WT
and class A samples. In fact, the clustering algorithm placed class A
embryos just as distantly from WT as class C from WT, implying that
gene expression differences in class A embryos, albeit not as
pronounced as in class C, may be sufﬁcient to compensate for the
Twsg1−/− genetic predisposition. Class B samples, representing an
intermediate phenotype, clustered alternatively with either class A or
class C. These results demonstrate that the variable morphological
features of individual embryos with the same genetic mutations inal differences between phenotypic classes of E10.5 embryos are displayed. Dotted lines
10 scale (y-axis) vs. an average ofWT samples (Y=1) for a given gene. Each vertical line
e differentially expressed between WT and class C, based on a fold change of 1.5 fold or
e expression levels, variation is greatest in themost severely affected embryos (class C).
fromWT and class A samples. Class B represents an intermediate phenotype, clustering
t the bottom.
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distinct transcriptional proﬁles.
Identiﬁcation of molecular and cellular effectors of craniofacial
phenotype in Twsg1 mutants
To study the association between phenotypic variability and
differential gene expression in more detail, we ﬁrst focused upon
samples representing the most divergent morphological classes, i.e.
WT vs. class C embryos. Microarray analysis identiﬁed 65 genes
(represented by 66 exon probe sets, including two sets for Rgs5) with
signiﬁcantly different, reproducible patterns of expression between
these classes (Fig. 2A and Supplemental Table 1). While most of these
full-length transcripts (82%) are downregulated in class C embryos, 12
transcripts (18%) are increased. To validate results from microarrays,
we performed Q-PCR on selected, differentially expressed transcripts.
The results closely corroborated those from microarrays (r=0.9541,
pb0.0001) (Figs. 2B–G). This high degree of reproducibility of the
microarray data was conﬁrmed further using independently isolated
mRNAs, by re-measuring expression levels of G-protein-coupled
receptor 50 (Gpr50), Bmp4, and BMP receptor, type 1B (Bmpr1b) by
Q-PCR (Fig. 2H). Again, a high concordance between microarray and
Q-PCR results exists across the different phenotypic classes (r=0.9321,
p=0.0003) (Fig. 2H).
Among those genes that are differentially expressed between WT
and class C mutants, 15 are known to be associated with craniofacial
defects in mice and/or humans (Table 1), as annotated by Mouse
Genome Informatics (MGI) and Online Mendelian Inheritance in Man
(OMIM). Several encode ligands (Bmp4, Bmp5), receptors (Bmpr1b)
and downstream targets of BMP signaling (Msx2; Pitx2) (Du and Yip,
2009; Schlange et al., 2002), which is consistent with the known role
of TWSG1 in modulating BMP signaling (Ross et al., 2001). Beyond
conﬁrming an expected role for BMPs in Twsg1−/− phenotypes,Fig. 2. Gene expression differences between wild type and severely affected mutants. (A) A
expression changes N1.5 fold andwith a false discovery rate of b10% are presented as rows. E
in Fig. 5 (B–G) Q-PCR conﬁrmation of expression values shown relative to the WT mean. *si
microarray data and Q-PCR data for genes in panels B–G (blue) and independent RNA samptranscriptome analysis facilitated identiﬁcation of additional candi-
date effectors of the craniofacial phenotype in Twsg1−/− mice. For
example, there is an inverse correlation between Dkk1 expression and
increasing phenotypic severity. Other genes showing a similar pattern
to Dkk1 include Alx1 (Zhao et al., 1996), Gata3 (Pandolﬁ et al., 1995),
Isl1 (Pfaff et al., 1996), or Pitx2 (Sclafani et al., 2006), each known to
play various roles in BA1 development, palate and craniofacial bone
morphology.
The genes that are differentially expressed between class C and WT
regulate a number of biological processes that are important for normal
craniofacial morphogenesis (Supplemental Table 2; top 12 molecular
and cellular functions represented by at least 3 molecules are shown
based on the p value), including apoptosis, which was identiﬁed
previously as a key cellular process that is altered in Twsg1−/− mice
(MacKenzie et al., 2009). In addition, a signiﬁcant number of
differentially expressed genes have been linked by Ingenuity Pathway
Analysis (IPA; Ingenuity® Systems, www.ingenuity.com) to “small
molecule biochemistry” and “lipid metabolism,” highlighting the
importance of cholesterol biosynthesis and metabolism of fatty acids
and acyl-CoA in normal craniofacial development (Muenke and Beachy,
2000).
To determine whether NCC are the cellular effectors of the
craniofacial phenotype in Twsg1−/− mice, we generated mice with
NCC-speciﬁc deletion of Twsg1 (Twsg1ﬂox/ﬂox;Sox10Cre). Sox10-Cre
mice express Cre recombinase in NCC, as early as a premigratory stage,
and in NCC derivatives, speciﬁcally the pharyngeal region (Matsuoka
et al., 2005; Muller et al., 2008). The phenotype of these mice
recapitulated the phenotype of global deletion of Twsg1 (MacKenzie
et al., 2009), but the effect was dependent on the efﬁciency of Cre-
mediated deletion of exon 4 of Twsg1 (Fig. 3). A reduction of Twsg1
level to less than 0.2% of the wild type expression in BA1 at E11.5
resulted in embryonic craniofacial defects, including hypoplasia and
fusion of the mandibular components of BA1, midline fusion of theheatmap displays gene expression changes compared to the average of WT. Genes with
ach column represents a biological replicate.☆ genes conﬁrmed by in situ hybridization
gniﬁcance in comparison with WT. (H) Scatter plot showing close correlation between
les (green) for Gpr50, Bmp4 and Bmpr1b.
Table 1





Associated human syndrome features (OMIM) Mouse knockout phenotype (MGI) Relative expression
A/WT B/WT C/WT C/A
Alx1 X Short mandible and maxilla, abnormal calvaria,
facial clefting
0.87 0.51a 0.24b 0.27b
Bmp4 X Microphthalmia/anopthalmia (OMIM #607932),
orofacial clefting (OMIM #600625)
Shortened frontal and nasal bones, agnathia 0.84 0.68a 0.37b 0.44b
Bmp5 X Small ears, small skull, short nasal bone, short
mandible, short maxilla, abnormal hyoid
0.67c 0.58c 0.56b 0.84
Bmpr1b X Short snout 1.01 1.11 1.59b 1.58b
Cyp26a1 X Branchial arch hypoplasia, abnormal facial/head
morphology, microcephaly
0.93 1.1 1.68b 1.81b
Dkk1 X Absent mandible, maxilla, nasal bone, abnormal
calvaria and BA1 morphology, microcephaly
0.91 0.70a 0.46b 0.50b
Dlk1 X Facial malformations (OMIM 176290) 1.24a 1.0 0.58b 0.47b
Evi1 X Abnormal branchial arch morphology 1.21a 1.16a 0.79b 0.66b
Eya4 X Abnormal palate morphology 1.19 1.06a 0.69b 0.58b
Gata3 X Abnormal craniofacial bone morphology 0.96 0.73a 0.51b 0.53b
Igf2 X Silver Russell Syndrome (OMIM #180860),
micrognathia, cleft palate (Bruce et al., 2009)
Variable cleft palate with (maternal) uniparental
disomy 7
1.12 0.92 0.70b 0.63b
Isl1 X Abnormal branchial arch morphology 0.74c 0.48c 0.30b 0.42b
Lhx8 X Cleft palate 1.35b 1.25a 0.56a 0.41c
Lrig3 X Abnormal craniofacial morphology, short snout 1.09a 1.19c 1.52b 1.39b
Msx2 X Craniosynostosis type 2 (OMIM #604757) Abnormal craniofacial development, cleft palate,
short snout, abnormal calvaria, teeth, middle
ear ossicles
0.95 0.78c 0.61b 0.64b
Pitx2 X Axenfeld-Rieger syndrome (OMIM #180500),
eye abnormalities, dental and maxillary
hypoplasia
Abnormal Meckel's cartilage, mandible, maxilla,
teeth, cleft palate
0.84c 0.82 0.64b 0.76b
Prrx2 X Micrognathia, abnormal maxilla, Meckel's cartilage,
middle ear ossicles, hyoid, ears, teeth, cleft palate
1.08 1.09 0.69b 0.63b
Ptch1 X Holoprosencephaly (OMIM #610828) Abnormal craniofacial morphology, abnormal
mandible, BA1
1.16 0.85 0.77a 0.66b
Satb2 X Isolated cleft palate (OMIM #119540) Micrognathia, premaxilla hypoplasia, abnormal
nasal capsule, microcephaly, cleft palate, tooth
abnormalities, short snout
1.42c 0.93 0.33b 0.23b
Sema3e X CHARGE syndrome (OMIM #214800), facial
dysmorphism, external ear abnormalities
0.89c 1.08 1.5c 1.7b
Sox2 X microphthalmia/anopthalmia (OMIM 184429) Abnormal palate morphology 0.71b 0.7a 0.59c 0.84
Tbx22 X X-linked cleft palate (OMIM #303400) with
or without ankyloglossia
Abnormal calvaria, cleft palate 1.29 1.32 0.48c 0.37c
Alx1, ALX homeobox 1; Bmp4, bone morphogenetic protein 4; Bmp5, bone morphogenetic protein 5; Bmpr1b, bone morphogenetic protein receptor, type 1B; Cyp26a1, cytochrome
P450, family 26, subfamily a, polypeptide 1; Dkk1, dickkopf homolog 1 (Xenopus laevis) or predicted gene, EG546723 or protein phosphatase 1, regulatory (inhibitor) subunit 2
(Ppp1r2); Dlk1, delta-like 1 homolog (Drosophila); Evi1, ecotropic viral integration site 1; Eya4, eyes absent 4 homolog (Drosophila); Gata3, GATA binding protein 3; Igf2, insulin-like
growth factor 2; Isl1, ISL1 transcription factor, LIM/homeodomain; Lhx8, LIM homeobox protein 8; Lrig3, leucine-rich repeats and immunoglobulin-like domains 3;Msx2, homeobox,
msh-like 2 or LOC100046255, similar to homeobox protein; Pitx2, paired-like homeodomain 2; Prrx2, paired related homeobox 2; Ptch1, patched homolog 1; Satb2, special AT-rich
sequence binding protein 2; Sema3e, sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E or hypothetical protein LOC100044162; Sox2, SRY
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vesicles.
Transcriptional changes between class A and class C mutants and their
functional signiﬁcance
Class A and class C embryos share the same genetic mutation in
Twsg1 but differ in the absence or presence of craniofacial defects.
Therefore we extended our analysis to genes that are differentially
expressed between these classes of mutants, as they may provide
new insights into mechanisms underlying variable disease expres-
sivity. We identiﬁed 80 genes that were differentially expressed
between affected and unaffected Twsg1−/− embryos (Supplemental
Table 1), including 41 additional transcripts that were not identiﬁed
in the WT vs. class C comparison. The number of genes that showed
opposite trends in class A vs. class C (Fig. 4A) signiﬁcantly increased
compared to the class C vs. WT comparison (Fig. 2A) by using this
approach. To highlight such changes, we grouped these differentially
expressed genes into various expression patterns: P1 includes genesdownregulated in class C; P2 genes upregulated in class A and
downregulated in class C; P3 the reverse trend of P2; and P4 genes
upregulated in class C (Fig. 4A).
Microarray results indicating differential gene expression between
phenotypic classes A and C were validated further by both Q-PCR
(Figs. 4B–F) and in situ hybridizations (Fig. 5). Despite their normal
external appearance, class A mutants show a marked increase in
expression for Plagl1, Satb2 and Peg3 (Figs. 5G–O). Other anatomic ex-
pression sites for thesegenes outsideBA1werenot affected in thevarious
classes of embryos, indicating a BA1-speciﬁc effect (data not shown).
The ontological categories of genes whose expression levels differ
between class A and class C are shown in Table 2. Again, apoptosis is
among the key biological processes. Tumor protein 53-induced nuclear
protein 1 (Trp53inp1) was identiﬁed among a set of genes that play a
role in regulating apoptosis, which are uniquely altered between
affected and unaffected mutants. Additional biological processes were
identiﬁed as distinguishing factors between affected and unaffected
embryos, including cellular assembly and organization, carbohydrate
metabolism, and DNA replication, recombination, and repair.
Fig. 3. The frequency of craniofacial defects in mice with NCC-speciﬁc deletion of Twsg1.
Twsg1ﬂox/ﬂox;Sox10Cre+embryos included both (A) normal appearing embryos (black
arrowheads point to the maxillary components of BA1; white arrowhead to the
mandibular component; n, nasal prominences; t, telencephalic vesicles) and (B) embryos
with craniofacial abnormalities, including fusionof themandibular arches, nasal processes,
and telencephalic vesicles (B′) Dissection of the mandibular andmaxillary components of
BA1 highlights hypoplasia and midline fusion of the mandibular prominences that
characterizes the severe Twsg1 phenotype. (C) Expression levels of Twsg1, measured using
primers to exon 4 and 5were compared between Twsg1ﬂox/ﬂox;Sox10Cre- and Twsg1ﬂox/ﬂox;
Sox10Cre+depending on the presence or absence of external craniofacial abnormalities. A
reduction of Twsg1 levels to less than 0.2% of the wild type expression in BA1 at E11.5
resulted in craniofacial defects. Both maxillary and mandibular prominences were
collected as shown in B′. Q-PCR was performed using individual mRNA samples. Three
embryos per group were analyzed, ***pb0.001 (compared to Twsg1ﬂox/ﬂox;Cre-embryos).
Fig. 4. Gene expression differences between unaffected and severely affected mutants.
(A) A heatmap of expression changes in various phenotypic classes was compared to
the average of WT. Genes with expression changes N1.5 fold and with a false discovery
rate of b10% are presented as rows. ★Imprinted genes. (B–F) Q-PCR conﬁrmation.
Signiﬁcance levels in comparison with WT (*) or with class A (†); three symbols
represent pb0.001; two, pb0.01; and one, pb0.05.
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identiﬁed in class C vs. WT embryo comparisons, but were identiﬁed
in comparisons of class A vs. C embryos, seven play known roles in
craniofacial development in mice and/or humans (Evi1, Eya4, Igf2, Lhx8,
Prrx2, Ptch1, Tbx22) (Braybrook et al., 2001; Bruce et al., 2009; Depreux
et al., 2008; Hoyt et al., 1997; Ming et al., 2002; ten Berge et al., 1998;
Zhao et al., 1999) (Table 1). Interestingly, each of these genes groups in
expression pattern P2. While each transcript showed less than 1.5-fold
decrease in expression in class C compared to WT, the difference from
class Awas accentuated by a small increase in their expression in class A
mutants. Since many of these genes may serve similar functions during
craniofacial development, it is plausible that additive effects of these
small changes may compensate for the loss of TWSG1 during BA1
morphogenesis, and protect class A embryos against manifestation of
disease. Other genes, including imprinted genes, also are upregulated in
class A and downregulated in class C, suggesting that they either are co-
regulatedwithin genenetworks important for craniofacial development
ormay play a direct role in craniofacial development (Feng et al., 2009).
Genetic deletion of p53 reduces incidence of craniofacial defects in
Twsg1−/− mice
Further comparison of class A vs. C differentially expressed
transcripts identiﬁed genes that are downregulated in class A and
upregulated in class C. This pattern (P3) was not observed in the
comparison between WT and class C mutants except for Sema3e.
Among them was a p53-inducible gene, Trp53inp1 (Tomasini et al.,
2003). The pattern of Trp53inp1 expression in the different pheno-
typic classes suggested that increased p53 activity could play a role inmediating the phenotype. Western blotting on whole embryos
demonstrated that p53 levels were, in fact increased in severely
affected homozygous mutants class C with lower levels of p53 in
unaffected homozygous mutants class A, or WT embryos (Fig. 6A).
Q-PCR analysis of Trp53inp1 transcript levels conﬁrmed microarray
data indicating upregulation of this gene in class C embryos with a
trend toward reduction in class A embryos compared to WT (Fig. 6B).
Based on upregulation of p53 and Trp53inp1 in class C embryos
that show the highest degree of apoptosis in BA1, and since sup-
pression of p53 prevents the neurocristopathy of Treacher-Collins
syndrome through inhibition of NCC apoptosis (Jones et al., 2008), we
hypothesized that a similar phenotypic rescue might be observed
after a genetic deletion of p53 on the Twsg1−/− background.
Progeny from Twsg1+/−p53+/− intercrosses or Twsg1+/−p53+/−
and Twsg1−/−p53+/− matings were analyzed (both neonates and
embryos at E17.5) for the presence of external craniofacial defects. The
rate of recovery of Twsg1−/−p53+/− and Twsg1−/−p53−/− genotypes
was consistent with the predicted distribution based on Mendelian
inheritance. The frequency of Twsg1-related craniofacial defects
signiﬁcantly decreased with a reduction of p53 gene dosage from
44% in Twsg1−/−p53+/+ pups (N=675) (Sun et al., 2010) to 30% in
Twsg1−/−p53+/− (N=47, p=0.04) and 15% in Twsg1−/−p53−/−
littermates (N=39, p=0.001) (Figs. 6C–G).While craniofacial defects
were prevented to a large degree by a loss of two copies of p53, there
Fig. 5. Validation of differential gene expression by in situ hybridization. Photomicrographs of embryos from different phenotype classes, probed by in situ hybridization for (A–C)
Dkk1 and (D–F) Msx2, show similar expression levels between WT and class A, but profoundly decreased expression in class C. (G–I) Plagl1, (J–L) Satb2 and (M–O) Peg3 show
increased expression in class A and markedly decreased expression in class C. These represent various patterns of differential gene expression as described in the text. Arrowheads
indicate expression domains within BA1. Fused mandibular prominences of BA1 are either marked with an asterisk or outlined with a dashed line.
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neonates (up to 66%), suggesting involvement of other organ systems.
As previously published, we observed that homozygous deletion of
p53 leads variably to exencephaly (Sah et al., 1995). This phenotype
appeared independently of Twsg1 genotype.
Imprinted genes are overrepresented among genes that are upregulated
in class A and downregulated in class C mutants
The various expression patterns deﬁned for groups of differentially
expressed genes may help identify a common regulatory mechanism
for each group. Interestingly, we found that group P2, with an increase
or a trend toward increase from WT in class A and a decrease in
expression in class C mutants, is highly enriched in imprinted genes.Table 2
Predicted biological processes regulated by genes uniquely altered between class A and cla
Molecular and cellular functions Highest p-value
Cellular movement 1.1E-02
Cell-to-cell signaling and interaction 1.32E-02
Cellular growth and proliferation 1.6E-02
Cellular assembly and organizationa 1.71E-02








DNA replication, recombination, and repaira 1.84E-02
a Processes identiﬁed as signiﬁcant based on class C vs. class A comparison, but not classUsing a list of imprinted loci (Morison et al., 2001, 2005), we
identiﬁed 68 transcript clusters corresponding to imprinted loci in the
array of 16755 transcript clusters. Of these 68, six are differentially
regulated between class A and class C: Plagl1 (Fig. 4B), Igf2 (Fig. 4C),
Dlk1 (Fig. 4D), paternally expressed 3 (Peg3) (Fig. 4F), ankyrin repeat
and SOCS box-containing protein 4 (Asb4), and maternally expressed 3
(Meg3). This proportion of imprinted genes is much higher than
predicted by chance, as indicated by a χ2 analysis yielding a p-value of
b2.92 10−23. To conﬁrm the enrichment of imprinted genes, a more
stringent approach was also taken. In this case, we estimated the
number of imprinted genes to represent 2.5% of the mouse genome
(Luedi et al., 2005). Finding six imprinted genes represented in the 81
differentially expressed transcript clusters was again highly signiﬁ-
cant, with a p value of b0.0046.ss C mutants.
List of molecules
DAB1, ENPP2, EPHA4, ETV5, FABP7, FOXF1, HGF, IGF2, UNC5C
ENPP3, FABP7, GRIK2, HGF, IGF2
DHCR24, ENPP2, ENPP3, EVI1, FABP7, FOXF1, HGF, IGF2, PRRX2,
PTCH1, TFAP2B, TP53INP1, UNC5C
DAB1, ENPP2, EPHA4, FABP7, HGF, IGF2, PTCH1, TFAP2B,
DHCR24, ENPP2, ENPP3, ELOVL6, FABP7, HGF, IGF2, TP53INP1,
FABP7, FOXF1, HGF, IGF2, LHX8, UNC5C
ENPP2, HGF, IGF2, TP53INP1
DHCR24, GRIK2, HGF, IGF2, MGST1, TFAP2B, TRP53INP1, UNC5C
EPHA4, EVI1, FABP7, HGF, IGF2
DHCR24, ELOVL6, ENPP2, FABP7, HGF
ENPP2, FABP7, HGF, IGF2, TP53INP1
ETV5, EVI1, FOXF1, HGF, IGF2, TBX22, TFAP2B
ENPP3, HGF, IGF2, PTCH1
C vs. wild type comparison.
Fig. 6. Prevention of craniofacial defects Twsg1−/−mice by a genetic deletion of p53. (A) Western blotting for p53 using whole E10.5 embryos indicates increased p53 protein levels
in Twsg1−/− class C, compared to Twsg1−/− class A or WT embryos. GAPDH levels were consistent across these samples (B) Q-PCR measurement of Trp53inp1 transcript levels
conﬁrms microarray data indicating upregulation of this gene in class C embryos with a trend toward reduction in class A embryos (C). Decreasing incidence of craniofacial defects
among Twsg1−/− pups is associated with reduced p53 gene dosage. *pb0.05, **pb0.01, ***p=0.001. Representative images of neonates with their corresponding genotypes, lateral
view (D–G) and frontal view (D′–G′).
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Differential gene expression is associated with Twsg1−/− phenotypic
severity
Transcriptional proﬁling has been used previously to identify
genes important in normal development of individual facial promi-
nences (Feng et al., 2009) as well as downstream targets of mutated
genes (Jeong et al., 2008). Mouse knockouts with variable phenotypes
present a particular challenge and an opportunity to gain insights into
the basis of this variability. For the ﬁrst time, we undertook an effort to
correlate phenotypic severity of craniofacial defects with changes in
the transcriptome, based on the premise that both unaffected and
affected Twsg1−/− mutants would show changes in gene expression
compared to WT mice and to each other.
We observed reproducible transcriptional proﬁles that cluster
into distinct groups, and are strongly associated with the observed
phenotypic categories in Twsg1−/− mice. This observation strongly
suggests that these transcriptional patterns help to deﬁne the
distinct morphological and functional groups of Twsg1−/− mice.
Among the genes that are differentially expressed between class C
andWT BA1, about 20% are associated directly with known human or
mouse craniofacial defects. Others may represent new candidategenes that may contribute to human craniofacial diseases. Most of
these genes are downregulated in class C mutants; since they
regulate development of similar craniofacial structures, their loss of
expression helps to explain observed craniofacial defects in Twsg1
mutants. As an example, signiﬁcantly reduced Dkk1 expression could
contribute to the anterior truncation phenotype (Mukhopadhyay
et al., 2001) of some Twsg1−/− mice.
We were able to distinguish transcript differences not only
between WT and affected mutants, but also between unaffected and
affected Twsg1−/− mutants. This led to three main conclusions. First,
class A Twsg1−/− embryos, despite appearing normal on a morpho-
logical level, are not “normal” on a molecular level. Second, genes that
are differentially expressed between the genetic mutants and the WT
embryos, but not differentially expressed between phenotypic class A
vs. class C mutants, presumably do not play a role in development of
the severe mutant phenotype. Third, genes that are differentially
expressed between class A and class C mutants may provide clues
about possible compensatory mechanisms that prevent class A
mutants from developing craniofacial defects. In particular, upregula-
tion of craniofacial genes which regulate development of BA1, palate,
maxilla, nasal capsule, and teeth (Evi1, Eya4, Igf2, Lhx8, Prrx2, Ptch1,
Satb2, and Tbx22) in class A mutants may compensate for the loss of
TWSG1 function during craniofacial morphogenesis.
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It has been suggested that NCC are particularly sensitive to cellular
stress during embryogenesis and that suppression of p53 can prevent
craniofacial defects in a murine model of Treacher-Collins syndrome
(Jones et al., 2008), Tcof1+/−mice. Our experiments showing a genetic
rescue of craniofacial defects in Twsg1−/− mice corroborate this data
and suggest that this approach may have broader implications for the
prevention of craniofacial defects by targeting the p53 pathway.
The end-result of increased p53 signaling in Tcof1+/− mice was
proposed to be an increase in NCC apoptosis and deﬁcient formation
of NCC, leading to craniofacial defects. Similarly, increased neuroe-
pithelial apoptosis is at the core of neural tube defects in Pax3-
deﬁcient embryos, which also can be rescued by a loss of p53 function
(Pani et al., 2002). We have previously shown that abnormal BA1
development in Twsg1−/− mice is also associated with increased
apoptosis, albeit at a later stage, once NCC have populated the
branchial arches (MacKenzie et al., 2009). Thus, an increase in
apoptosis is a common link between these mouse models of birth
defects, which each shows phenotypic rescue by suppression of p53.
In Twsg1−/−mice, this increase in apoptosis is thought to be due to
disruption of a BMP gradient in BA1 (MacKenzie et al., 2009). While
BMPs are known to have proapoptotic effects during embryonic
development (Graham et al., 1994; Mina et al., 2002), understanding
of downstreammolecular mechanisms remains limited. There is some
evidence from in vitro studies that BMP4-induced apoptosis may be
p53-dependent (Fukuda et al., 2006). Interestingly, BMPs have been
implicated in modulating cellular responses to stress and TWSG1 as a
modulator of BMPs (Oelgeschläger et al., 2000; Ross et al., 2001)
would also hence be implicated in this process. For example, BMP7
can have a direct antioxidative effect in the kidneys and in neurons
(Tsai et al., 2007; Yeh et al., 2009). On the other hand, BMP2 and BMP4
have been shown to have pro-oxidative stress effects in endothelial
cells (Csiszar et al., 2006, 2008; Wong et al., 2010). With TWSG1's
bifunctional role, being able to either promote or inhibit BMP
signaling depending on context, the effects on modulation of stress
may also be context dependent. We propose that the cell's variable
ability to cope with stress may underlie the variable apoptosis and
phenotypic variability. The effectors and drivers of this adaptability
are not yet known.Fig. 7.Model for interrelated processes leading to craniofacial phenotypes and craniofacial ph
BA1, which leads to mispatterning of BA1, increased cellular stress, increased apoptosis, a
reduction in BMP targets and other genes expressed in the distal region of BA1 and evoke stre
compounded by likely changes in the epigenome as well as stochastic ﬂuctuations in geneA possible role for epigenetic regulation of craniofacial phenotypes
cannot be excluded in view of a growing body of evidence that
epigenetic phenomena contribute to phenotypic variability in humans
and mice (Dolinoy et al., 2007; Whitelaw and Martin, 2001). Imprinted
genes are known genomic targets of epigenetic regulation (Waterland
and Jirtle, 2004).Whether they also play a role in generating craniofacial
variability remains to be determined. While several imprinted genes
have been previously shown to be overrepresented in the mandibular
prominence compared to the maxillary prominence or the frontonasal
prominence in wild type mouse embryos (Feng et al., 2009), our study
suggests that altered regulation of the imprinted genes may contribute
to generating phenotypic variation in Twsg1−/−mice. Notably, most of
these genes show gains and losses of expression between unaffected
class A and affected class C Twsg1−/−mutants, respectively. Other genes
showing this expression pattern also are known to mediate epigenetic
effects during development and disease, for example Satb2 (Gyorgy
et al., 2008), Evi1 (Spensberger and Delwel, 2008), Eya4 (Osborn et al.,
2006), and Ptch1 (Diede et al., 2010). Several “metastable epialleles”
have been described in mice (Avy, AxinFu, CabpIAP) (Dolinoy, 2007;
Druker et al., 2004; Rakyan et al., 2003; Waterland and Jirtle, 2003),
although none that would confer predisposition to the development of
craniofacial defects. Stress response, epigenetics, and gene expression
can be interrelated. P53 can interactwith bothDNAmethyltransferase 1
(DNMT1) and DNMT3a to alter gene methylation (Esteve et al., 2005;
Gibney and Nolan, 2010; Wang et al., 2005). Cellular stress can also
change the expressionof imprintedgenes, including Igf2, H19, andMeg3,
independent of the stress-responsive tumor suppressors, for example
due to denovomethylation in cancer cells (Pantoja et al., 2005). Cellular
stress and methylation are also both impacted by shared biochemical
pathways in the metabolism of folate, homocysteine and the synthesis
of glutathione (Chern et al., 2001; Tchantchou, 2006) Future studieswill
examine global methylation patterns in various classes of Twsg1
mutants to determine if there is indeed a role for epigenetic regulation
of craniofacial phenotypes and to identify targets of such regulation.
Multifactorial model of craniofacial defects in Twsg1−/− mice
We have developed a model that integrates various processes that
may be involved in establishing phenotypic variation in Twsg1−/−
mutant mice (Fig. 7). The most immediate effect, which has beenenotypic variability in Twsg1−/−mice. Loss of TWSG1 disrupts the BMP gradient within
nd reduced outgrowth. Apoptotic tissue loss and loss of peak BMP activity lead to a
ss andmetabolic responses as well as compensatory changes in gene expression. This is
expression and signaling pathways, leading to phenotypic variation.
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loss of the normal BMP signaling gradient, leading to mispatterning of
BA1, reduced outgrowth and excessive apoptosis (MacKenzie et al.,
2009). Loss of tissue by apoptosis and loss of peak BMP activity lead to
a reduction in BMP targets and other genes expressed in the distal
region of BA1, and evoke compensatory changes in gene expression,
changes in cellular metabolism and stress responses. These effects
presumably are compounded by stochastic ﬂuctuations in gene ex-
pression and signaling pathways (Melnick et al., 2006; Spudich and
Koshland, 1976), and possibly by changes in the epigenome at various
regulatory elements.
Conclusions
We show here that phenotypic classes of Twsg1−/− embryos are
associated strongly with distinct patterns of differentially expressed
transcripts. This suggests that the phenotypic variation observed in
Twsg1−/− mice may be caused by heretofore unidentiﬁed “master
regulators” which in turn would bring about coordinate changes in
expression of many downstream genes. An initiating event is
disruption of BMP signaling in BA1 of Twsg1−/− mice that evokes a
number of cellular andmolecular responses, including a cellular stress
response, which appears to play a key role in the pathogenesis of
craniofacial defects. Occurrence of these defects can be suppressed by
a reduction in p53 dosage. Further study of transcriptional, and
probably epigenetic, contributions to phenotypic variation may not
merely explain the wide variation of craniofacial phenotypes in
clinical craniofacial syndromes, but also suggest how craniofacial
morphological diversity might be enhanced through evolutionary
processes (Brugmann et al., 2006). That the face is a key site for
morphological evolution is suggested by the wide diversity of
craniofacial adaptations in vertebrates (Brugmann et al., 2006). To
provide the phenotypic “space” for these adaptations, craniofacial
development must be particularly plastic. The changes we observe
highlight the extreme plasticity of transcriptional and likely the
epigenetic states of genes involved in craniofacial development.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.04.026.
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